Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis.
about
Osteoarthritis pain mechanisms: basic studies in animal modelsTargets, models and challenges in osteoarthritis researchConcurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) modelIncreasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip.Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH)A store-operated calcium channel inhibitor attenuates collagen-induced arthritis.Electroacupuncture Confers Antinociceptive Effects via Inhibition of Glutamate Transporter Downregulation in Complete Freund's Adjuvant-Injected Rats.Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway.Calcitonin gene-related peptide receptor antagonists: beyond migraine pain--a possible analgesic strategy for osteoarthritis?Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1/EP2/EP4 receptor pathway in synovium of knee osteoarthritis patients.Cannabinoids: novel therapies for arthritis?A review of translational animal models for knee osteoarthritis.In vivo luminescence imaging of NF-κB activity and serum cytokine levels predict pain sensitivities in a rodent model of osteoarthritis.Protease-activated receptor 2 in dorsal root ganglion contributes to peripheral sensitization of bone cancer pain.The anti-arthritic activity of total glycosides from Pterocephalus hookeri, a traditional Tibetan herbal medicine.Proteasomal function is impaired in human osteoarthritic chondrocytes and this can contribute to decreased SOX9 and aggrecan.
P2860
Q26849681-170DD74F-FB97-4114-A515-A83766083361Q26850147-016A58DF-C0B3-460D-B03E-D1A138C2585FQ28829244-AF174379-3ADC-421D-A638-48F17D6FF235Q35061327-5BE7D37C-6022-405E-AE78-E04207954EFAQ35123812-5FA7CC39-7C18-4AC1-9979-6B147B3602E2Q35692995-29451DA7-882F-44CA-A42A-FA85E3C70ECEQ36204555-EB4F0767-9065-41AD-97F2-EEA78BE1090FQ37109706-C9F85F3F-2197-4D34-BA04-403BECB73EEAQ37298648-9D8DDE5A-327E-450D-81E5-3C7212C6C55BQ37346133-26047FA7-20ED-4B7B-8D5D-2E65AB4DECC1Q38005189-364F6733-FC6D-40C2-A24B-150EE801051CQ38074652-1C90C033-6DA6-4B47-A4DC-5F43097B9482Q38949744-4017AB1C-B458-477A-970B-D23B5E9AC6B7Q39119150-05FC9774-8C69-4DB3-AF18-D9A87C9E7F87Q47250635-24A0BADA-4A16-4DE3-9685-9E745AC9E891Q49860309-7EBDA56C-62BD-48D9-8E72-EEB487E9A939
P2860
Suppression of pain and joint destruction by inhibition of the proteasome system in experimental osteoarthritis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Suppression of pain and joint ...... n experimental osteoarthritis.
@en
Suppression of pain and joint ...... n experimental osteoarthritis.
@nl
type
label
Suppression of pain and joint ...... n experimental osteoarthritis.
@en
Suppression of pain and joint ...... n experimental osteoarthritis.
@nl
prefLabel
Suppression of pain and joint ...... n experimental osteoarthritis.
@en
Suppression of pain and joint ...... n experimental osteoarthritis.
@nl
P50
P1433
P1476
Suppression of pain and joint ...... n experimental osteoarthritis.
@en
P2093
Helena Erlandsson-Harris
P356
10.1016/J.PAIN.2011.08.001
P407
P577
2011-10-22T00:00:00Z